Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY – Get Free Report) was the recipient of a large drop in short interest in October. As of October 30th, there was short interest totaling 138,641 shares, a drop of 89.7% from the October 15th total of 1,348,635 shares. Based on an average trading volume of 269,329 shares, the days-to-cover ratio is currently 0.5 days. Currently, 0.0% of the shares of the stock are short sold.
Coloplast A/S Stock Down 2.9%
Shares of OTCMKTS CLPBY opened at $7.32 on Wednesday. Coloplast A/S has a 1 year low of $5.64 and a 1 year high of $9.50. The firm’s 50 day moving average price is $6.87 and its 200 day moving average price is $6.78. The firm has a market cap of $16.50 billion, a P/E ratio of 19.33, a price-to-earnings-growth ratio of 3.51 and a beta of 0.10. The company has a debt-to-equity ratio of 1.51, a quick ratio of 0.94 and a current ratio of 1.56.
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last released its earnings results on Tuesday, November 3rd. The company reported $0.09 EPS for the quarter, hitting the consensus estimate of $0.09. The firm had revenue of $1.12 billion during the quarter, compared to analysts’ expectations of $1.12 billion. Coloplast A/S had a net margin of 10.57% and a return on equity of 42.25%. As a group, sell-side analysts anticipate that Coloplast A/S will post 0.39 earnings per share for the current year.
Analyst Ratings Changes
Separately, Barclays upgraded shares of Coloplast A/S from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, November 3rd. Two research analysts have rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy”.
Check Out Our Latest Report on CLPBY
About Coloplast A/S
Coloplast A/S is a Danish medical device company that develops and markets products and services for people with intimate health care needs. Its main business areas include ostomy care, continence care, wound and skin care, and urology care. Its products include ostomy bags and accessories, catheters and other continence products, wound dressings, and devices used in urological procedures. Coloplast also provides voice and respiratory care products, including solutions for people who have had a laryngectomy.
Read More
- Five stocks we like better than Coloplast A/S
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.
